The treatment versus experimentation dilemma in dose finding studies

Journal of Statistical Planning and Inference

Volumn 141, Issue 8, 2011, Pages 2759-2768

  Azriel, D ^a   Mandel, M ^a   Rinott, Y ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Isotonic regression; Maximum tolerated dose; Phase I trial; Stochastic approximation; Up and down design

Indexed keywords

EID: 79954622444     PISSN: 03783758     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jspi.2011.03.001     Document Type: Article

References (21)

1. Babb J., Rogatko A., Zacks S. Cancer phase I clinical trials: efficient dose escalation with overdose control. Statistics in Medicine 1998, 17:1103-1120.
2. Barlow R.E., Bartholomew D.J., Bremner J.M., Brunk H.D. Statistical Inference Under Order Restrictions 1972, Wiley, London, New York.
3. Bartroff J., Lai T.L. Approximate dynamic programming and its applications to the design of phase I cancer trials. Statistical Science 2010, 25:245-257.
4. Cheung Y.K., Chappell R. A simple technique to evaluate model sensitivity in the continual reassessment method. Biometrics 2002, 58:671-674.
5. Derman C. Non-parametric up-and-down experimentation. Annals of Mathematical Statistics 1957, 28:795-798.
6. Dixon W.J., Mood A.M. A method for obtaining and analyzing sensitivity data. Journal of the American Statistical Association 1948, 43:109-126.
7. Gasparini M., Eisele J. Curve-free method for phase I clinical trials. Biometrics 2000, 56:609-615.
8. Ivanova A., Bolognese J.A., Perevozskaya I. Adaptive design based on t-statistic for dose-response trials. Statistics in Medicine 2008, 27:1581-1592.
9. Ivanova A., Flournoy N., Chung Y. Cumulative cohort design for dose-finding. Journal of Statistical Planning and Inference 2007, 137:2316-2327.
10. Ivanova A., Haghighi A., Mohanty S., Durham S. Improved up-and-down designs for phase I trials. Statistics in Medicine 2003, 22:69-82.
11. Ivanova A., Kim S.H. Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach. Biometrics 2009, 65:307-315.
12. Lai T.L., Robbins H. Iterated least squares in multiperiod control. Advances in Applied Mathematics 1982, 3:50-73.
13. Leung D.H., Wang Y.G. Isotonic designs for phase I trials. Controlled Clinical Trials 2001, 22:126-138.
14. Mukerjee H.G. A stochastic approximation by observation on a discrete lattice using isotonic regression. The Annals of Statistics 1981, 9:1020-1025.
15. O'Quigley J. Theoretical study of the continual reassessment method. Journal of Statistical Planning and Inference 2006, 136:1765-1780.
16. O'Quigley J., Pepe M., Fisher L. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. Biometrics 1990, 46:33-48.
17. O'Quigley J., Zohar S. Experimental designs for phase I and phase I/II dose-finding studies. British Journal of Cancer 2006, 94:609-613.
18. Shen L.Z., O'Quigley J. Consistency of continual reassessment method under model misspecification. Biometrika 1996, 83:395-405.
19. Shiryaev, A.N. (translated by R.P. Boas.), 1996. Probability, second ed. Springer, New York.
20. Shu J., O'Quigley J. Dose-escalation designs in oncology: ADEPT and the CRM. Statistics in Medicine 2008, 27:5345-5353.
21. Whitehead J., Thygesen H., Whitehead A. A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicity. Statistics in Medicine 2010, 29:1808-1824.